Keywords and phrases: meta-analysis, Bayesian, binomial-normal, normal-normal, risk difference, robustness, MCMC.
Received: December 7, 2021; Revised: January 31, 2022; Accepted: March 10, 2022
How to cite this article: S. Sumathi and Dr. B. Senthil Kumar, A comparative analysis of risk difference on sparse data through Bayesian models, Advances and Applications in Statistics 76 (2022), 105-126. http://dx.doi.org/10.17654/0972361722038
This Open Access Article is Licensed under Creative Commons Attribution 4.0 International License
References:
[1] D. K. Bhaumik, A. Amatya, S.-L. Normand, J. Greenhouse, E. Kaizar, B. Neelon and R. D. Gibbons, Meta-analysis of rare binary adverse event data, J. Amer. Stat. Assoc. 107(498) (2012), 555-567. [2] M. J. Bradburn, J. J. Deeks, J. A. Berlin and A. Russell Localio, Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events, Stat. Med. 26(1) (2007), 53-77. [3] T. Cai, L. Parast and L. Ryan, Meta-analysis for rare events, Stat. Med. 29(20) (2010), 2078-2089. [4] J. B. Carlin, Meta-analysis for tables: a Bayesian approach, Stat. Med. 11(2) (1992), 141-158. [5] P. Cummings, The relative merits of risk ratios and odds ratios, Archives of Pediatrics and Adolescent Medicine 163(5) (2009), 438-445. [6] M. J. Sweeting, A. J. Sutton and P. C. Lambert, What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data, Stat. Med. 23(9) (2004), 1351-1375. [7] J. O. Friedrich, N. K. Adhikari and J. Beyene, Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data, BMC Medical Research Methodology 7 (2007), Article number: 5. [8] A. Gelman, Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper), Bayesian Analysis 1(3) (2006), 515-534. [9] Z. Hu, J. Liang, Z. Wang, T. Tian, X. Zhou, J. Chen and H. Shen, Common genetic variants in pre-micro RNAs were associated with increased risk of breast cancer in Chinese women, Human Mutation 30(1) (2009), 79-84. [10] D. Liu, R. Y. Liu and M.-G. Xie, Exact meta-analysis approach for discrete data and its application to 2 × 2 tables with rare events, J. Amer. Stat. Assoc. 109(508) (2014), 1450-1465. [11] D. Makowski, D. Wallach and M. Tremblay, Using a Bayesian approach to parameter estimation: comparison of the GLUE and MCMC methods, Agronomie 22(2) (2002), 191-203. [12] R Core Team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria, 2016. [13] L. Scrucca, A. Santucci and F. Aversa, Competing risk analysis using R: an easy guide for clinicians, Bone Marrow Transplantation 40(4) (2007), 381-387. [14] A. M. Skene and J. C. Wakefield, Hierarchical models for multicentre binary response studies, Stat. Med. 9(8) (1990), 919-929. [15] M. Subbiah and M. R. Srinivasan, Classification of sparse data sets with zero cells, Statist. Probab. Lett. 78(18) (2008), 3212-3215. [16] A. J. Sutton, K. R. Abrams, D. R. Jones, T. A. Sheldon and F. Song, Methods for Meta-analysis in Medical Research, Vol. 348, Wiley, Chichester, 2000. [17] L. Tian, T. Cai, M. A. Pfeffer, N. Piankov, P.-Y. Cremieux and L. Wei, Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent tables with all available data but without artificial continuity correction, Biostatistics 10(2) (2009), 275-281. [18] W. Viechtbauer, Confidence intervals for the amount of heterogeneity in metaanalysis, Stat. Med. 26(1) (2007), 37-52. [19] D. Warn, S. Thompson and D. Spiegelhalter, Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales, Stat. Med. 21(11) (2002), 1601-1623. [20] J. Zhang, B. P. Carlin, J. D. Neaton, G. G. Soon, L. Nie, R. Kane, B. A. Virnig and H. Chu, Network meta-analysis of randomized clinical trials: reporting the proper summaries, Clinical Trials 11(2) (2014), 246-262. [21] P. P. Schnurr and B. L. Green, Trauma and health: physical health consequences of exposure to extreme stress, American Psychological Association, 2004. [22] Y. Chen, C. Hong, Y. Ning and X. Su, Meta‐analysis of studies with bivariate binary outcomes: a marginal beta‐binomial model approach, Stat. Med. 35(1) (2016), 21-40. [23] A. A. Veroniki, D. Jackson, W. Viechtbauer, R. Bender, J. Bowden, G. Knapp, O. Kuss, J. P. T. Higgins, D. Langan and G. Salanti, Methods to estimate the between‐study variance and its uncertainty in meta‐analysis, Res. Synth. Methods 7(1) (2016), 55-79. [24] Y. Zhou, J. Wang, Z. Gu, S. Wang, W. Zhu, J. L. Aceña and H. Liu, Next generation of fluorine-containing pharmaceuticals, compounds currently in phase II-III clinical trials of major pharmaceutical companies: new structural trends and therapeutic areas, Chemical Reviews 116(2) (2016), 422-518. [25] E. F. Binder, K. B. Schechtman, A. A. Ehsani, K. Steger-May, M. Brown, D. R. Sinacore, K. E. Yarasheski and J. O. Holloszy, Effects of exercise training on frailty in community-dwelling older adults: results of a randomized, controlled trial, Journal of the American Geriatrics Society 50(12) (2002), 1921-1928.
|